TRIUMEQ
TRIUMEQ
Approved
DIN Number
02430932
Drug Class
Human
Market Date
Oct 22, 2014
Company
HC
viiv healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02430932
AIG Number0355990001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J05AR13 LAMIVUDINE, ABACAVIR AND DOLUTEGRAVIR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:18.08.20
Health Canada Classification
ACTIVE INGREDIENTS (3)
ABACAVIR (ABACAVIR SULFATE)Active
Strength: 600 MG
Monograph: ABACAVIR (ABACAVIR SULFATE)
DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)Active
Strength: 50 MG
Monograph: DOLUTEGRAVIR (DOLUTEGRAVIR SODIUM)
LAMIVUDINEActive
Strength: 300 MG
Monograph: LAMIVUDINE